Lena Quambusch, Ph.D.
Affiliations: | 2017-2022 | Chemical Biology | TU Dortmund |
Area:
Chemical Biology, Stucture-Based Drug Design, Covalent-InhibitorsGoogle:
"Lena Quambusch"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
van der Westhuizen L, Weisner J, Taher A, et al. (2022) Covalent allosteric inhibitors of Akt generated using a click fragment approach. Chemmedchem |
Quambusch L, Depta L, Landel I, et al. (2021) Cellular model system to dissect the isoform-selectivity of Akt inhibitors. Nature Communications. 12: 5297 |
Landel I, Quambusch L, Depta L, et al. (2020) Spotlight on AKT: Current Therapeutic Challenges. Acs Medicinal Chemistry Letters. 11: 225-227 |
Quambusch L, Landel I, Depta L, et al. (2019) Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity. Angewandte Chemie (International Ed. in English) |
Uhlenbrock N, Smith S, Weisner J, et al. (2019) Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt. Chemical Science. 10: 3573-3585 |
Weisner J, Landel I, Reintjes C, et al. (2019) Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer. Cancer Research |
Tesch R, Becker C, Müller MP, et al. (2018) An Unusual Intramolecular Halogen Bond guides Conformational Selection. Angewandte Chemie (International Ed. in English) |
Rauh D, Bührmann M, Hardick J, et al. (2017) Covalent Lipid Pocket Ligands Targeting p38α MAPK Mutants. Angewandte Chemie (International Ed. in English) |